The company explicitly noted, "Sales and marketing expenses were $10.5 million, up 22%, driven by severance expenses, seasonal increases in performance marketing and headcount-related expenses," ...

Structure Therapeutics (GPCR) announced the pricing of its upsized underwritten public offering, to generate gross proceeds of approximately $650 million. The company's offering was upsized from a ...

The IRS urges taxpayers to get organized now to take advantage of changes under the One Big Beautiful Bill Act (OBBBA) that could impact tax deductions and refunds in the next tax filing season. As ...

Good day, and thank you for standing by. Welcome to the Structure Therapeutics top line results from the aleniglipron Phase II Access Program. [Operator Instructions] Please be advised that today's ...

The IRS has released its guidance for the “no tax on tips” and “no tax on overtime” provisions of the One Big Beautiful Bill Act (OBBBA), for workers who can claim the deductions for the 2025 tax year ...

Welcome to our next QIAGEN Deep Dive. Today, we will focus on our Sample Technologies business. The sample is the starting point of every discovery of every molecular workflow. Preparing a sample and ...

Santiago Donato: Good morning, everyone. I’m Santiago Donato, Investor Relations Officer of IRSA, and I welcome you to the First Quarter 2026 Results Conference Call. First of all, I would like to ...

Good morning, everyone. I'm Santiago Donato, Investor Relations Officer of IRSA, and I welcome you to the First Quarter 2026 Results Conference Call. First of all, I would like to remind you that both ...

IRS has a 10-year window to collect back taxes – but for many Americans, that doesn’t mean the debt simply disappears. The IRS Collection Statute Expiration Date (CSED) generally gives the government ...